<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01447836</url>
  </required_header>
  <id_info>
    <org_study_id>SLICG</org_study_id>
    <secondary_id>2011180</secondary_id>
    <nct_id>NCT01447836</nct_id>
  </id_info>
  <brief_title>Indocyanine Clearance Rate and Septic Liver Injury</brief_title>
  <official_title>Prognostic Value of Indocyanine Clearance Rate for Sepsis Patients in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver injury is a complication of sepsis and septic liver injury has adverse impact upon the
      outcome. As a measurement for liver function, Plasma clearance rate of indocyanine green
      (PDR-ICG) always decreased during the early phase of sepsis. So the investigators hypotheses
      include: PDR-ICG is lower in sepsis patients than non-septic patients in ICU; PDR-ICG may be
      lower in abdominal sepsis patients than non-abdominal sepsis patients in ICU; PDR-ICG
      correlates with abdominal perfusion pressure; change of PDR-ICG in early phase correlates
      with change of transaminase or bilirubin in late phase of sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Liver injury is a complication of sepsis and septic liver injury has adverse impact upon the
      outcome. However, changes of transaminase or bilirubin are always not significant during the
      early phase of sepsis. As another sort of measurement of liver function, plasma clearance
      rate of indocyanine green (PDR-ICG) always decreased during the early phase of sepsis. So the
      investigators hypotheses include: PDR-ICG may be lower in sepsis patients than non-septic
      patients in ICU; PDR-ICG may be lower in abdominal sepsis patients than non-abdominal sepsis
      patients in ICU; PDR-ICG correlates with abdominal perfusion pressure; change of PDR-ICG in
      early phase may correlate with change of transaminase or bilirubin in late phase of sepsis.
      Through this study we also plan to calculate the range of abdominal perfusion pressure that
      can maintain normal PDR-ICG and the range of PDR-ICG that can maintain normal transaminase or
      bilirubin level in sepsis patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma clearance of indocyanine green</measure>
    <time_frame>D0, D1, D2</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transaminase</measure>
    <time_frame>D0, D1, D2, D4, D6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bilirubin</measure>
    <time_frame>D0, D1, D2, D4, D6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prothrombin time</measure>
    <time_frame>D0, D1, D2, D4, D6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate</measure>
    <time_frame>D0, D1, D2, D4, D6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>γ-glutamyl transpeptidase</measure>
    <time_frame>D0, D1, D2, D4, D6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholinesterase</measure>
    <time_frame>D0, D1, D2, D4, D6</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Sepsis</arm_group_label>
    <description>Sepsis patients who are admitted to SICU of our clinical center.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Postoperative patients who underwent abdominal surgery and then was directly transferred to SICU of our clinical center.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood for transaminase, hemoglobin, prothrombin time, lactate and oxygen pressure test.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to SICU of our clinical center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For control group: the patient does not match the diagnosis criteria of sepsis before
             the operation; the operation was done in peritoneal cavity; the patient is transferred
             to SICU directly from surgical room or recovery room; the patient is anticipated to
             stay in SICU for more than 48 hours.

          -  For study group: the patient matches the diagnosis criteria of sepsis; the patient is
             anticipated to stay in SICU for more than 48 hours.

        Exclusion Criteria:

          -  Pregnancy

          -  Age &lt; 18 years

          -  The infection is purely caused by virus

          -  Obstruction of biliary tract, or acute cholangitis, or acute liver abscess, or active
             hepatitis, or hyperacute/acute liver rejection occurs during study period

          -  Hemorrhagic shock occurs during study period

          -  Asthma occurs during study period

          -  Acute coronary syndrome occurs during study period

          -  Continuing peripheral circulation dysfunction leads to refractory &quot;low quality&quot; during
             PDR-ICG measurement

          -  Comorbidity of the bladder leads to impossibility to measure intra-abdominal pressure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guanxiang Dong, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Surgical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guanqing Sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Surgical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guanqing Sun</last_name>
    <phone>+86-15602380755</phone>
    <email>speczhl@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Surgical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guanqing Sun, MD</last_name>
      <phone>+86-15602380755</phone>
      <email>speczhl@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Guanqing Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med. 2000 Dec;28(12):3799-807.</citation>
    <PMID>11153617</PMID>
  </reference>
  <reference>
    <citation>Sakka SG, Reinhart K, Meier-Hellmann A. Does the optimization of cardiac output by fluid loading increase splanchnic blood flow? Br J Anaesth. 2001 May;86(5):657-62.</citation>
    <PMID>11575341</PMID>
  </reference>
  <reference>
    <citation>Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock. 2002 Jun;17(6):451-8.</citation>
    <PMID>12069179</PMID>
  </reference>
  <reference>
    <citation>Mizushima Y, Tohira H, Mizobata Y, Matsuoka T, Yokota J. Assessment of effective hepatic blood flow in critically ill patients by noninvasive pulse dye-densitometry. Surg Today. 2003;33(2):101-5.</citation>
    <PMID>12616369</PMID>
  </reference>
  <reference>
    <citation>Inal MT, Memiş D, Kargi M, Sut N. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. J Crit Care. 2009 Sep;24(3):329-34. doi: 10.1016/j.jcrc.2008.11.012. Epub 2009 Feb 12.</citation>
    <PMID>19327336</PMID>
  </reference>
  <reference>
    <citation>Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010 Nov;38(11):2229-41. doi: 10.1097/CCM.0b013e3181f17bf9. Review.</citation>
    <PMID>20729729</PMID>
  </reference>
  <reference>
    <citation>Kortgen A, Paxian M, Werth M, Recknagel P, Rauchfuss F, Lupp A, Krenn CG, Müller D, Claus RA, Reinhart K, Settmacher U, Bauer M. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock. 2009 Oct;32(4):358-65. doi: 10.1097/SHK.0b013e31819d8204.</citation>
    <PMID>19197231</PMID>
  </reference>
  <reference>
    <citation>Slotman GJ, Fisher CJ Jr, Bone RC, Clemmer TP, Metz CA. Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1993 Feb;21(2):191-5.</citation>
    <PMID>8428468</PMID>
  </reference>
  <reference>
    <citation>Seibel A, Sakka SG. [Indocyanine green plasma disappearance rate: estimation of abdominal perfusion disturbances]. Anaesthesist. 2010 Dec;59(12):1091-8. doi: 10.1007/s00101-010-1754-2. Epub 2010 Aug 18. German.</citation>
    <PMID>20714702</PMID>
  </reference>
  <reference>
    <citation>Mathes AM, Kubulus D, Weiler J, Bentley A, Waibel L, Wolf B, Bauer I, Rensing H. Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats. Crit Care Med. 2008 Jan;36(1):24-9.</citation>
    <PMID>18090374</PMID>
  </reference>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 4, 2011</study_first_submitted>
  <study_first_submitted_qc>October 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2011</study_first_posted>
  <last_update_submitted>October 5, 2011</last_update_submitted>
  <last_update_submitted_qc>October 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Guanqing Sun</investigator_full_name>
    <investigator_title>Resident doctor</investigator_title>
  </responsible_party>
  <keyword>indocyanine green</keyword>
  <keyword>sepsis</keyword>
  <keyword>liver injury</keyword>
  <keyword>abdominal perfusion pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

